Product News
Oxford Nanopore and Day Zero Diagnostics Partner To Develop a New Class of Bloodstream Infection Diagnostics
Oxford Nanopore, and Day Zero Diagnostics (DZD), announced a collaboration to develop an end-to-end solution for the diagnosis of bloodstream infections, a leading cause of sepsis.
Product News
Tune Therapeutics Reveals Epigenetic Editing Program Targeting Hepatitis B Virus
The mechanism targets both integrated virus and cccDNA; expected to begin clinical testing by end of 2024. Preclinical program data to be presented at the 2023 Hep DART Conference .
Product News
Glox Therapeutics Secures £4.3M Seed Funding to Develop Precision Antimicrobials Targeting Drug-resistant Bacteria
Glox Therapeutics, announced it has raised £4.3M in seed funding to develop effective targeted therapeutics against antibiotic-resistant Gram-negative bacteria.
Product News
Bio-Rad Extends Range of Anti-Idiotypic Antibodies for Use in Preclinical and Clinical Drug Development
Range of highly selective anti-idiotypic antibodies now includes six antibodies specific to dupilumab and its biosimilars for bioanalysis and Drug Monitoring.
Product News
Custom Monoclonal Antibody Reveals Promising HER2+ Breast Cancer Target
AMSBIO has supplied a custom monoclonal antibody (mAB) to researchers at the TU Dortmund** in Germany to unravel the role of EDI3 in breast cancer development.
Product News
GADx’s Rapid Diagnostic Test, BotrytisAlert, Demonstrates Utility Across Wine Production System
Lateral flow test enables Botrytis concentration to be measured in grape must and in finished wine, in addition to monitoring in the vineyard.
Advertisement
